Cargando…

Chagas disease and perceived quality of life: a cross-sectional study

BACKGROUND: Chagas disease (ChD) is a neglected tropical disease that is caused by the protozoan parasite Trypanosoma cruzi and can negatively impact quality of life (QoL). This study aimed to assess and compare QoL between individuals with and without ChD. METHODS: This cross-sectional study was pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baldoni, Nayara Ragi, Quintino, Nayara Dornela, Oliveira, Claudia Di Lorenzo, da Silva, José Luiz Padilha, Ferreira, Ariela Mota, Ribeiro, Antonio Luiz Pinho, Sabino, Ester Cerdeira, Cardoso, Clareci Silva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Medicina Tropical - SBMT 2023
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615335/ https://www.ncbi.nlm.nih.gov/pubmed/37909506 http://dx.doi.org/10.1590/0037-8682-0206-2023

Ejemplares similares

Quality of life in patients with Chagas disease and the instrument used: an integrative review
por: Baldoni, Nayara Ragi, et al.
Publicado: (2021)

Evaluation of the properties of WHODAS-12 measurements in individuals with Chagas disease in Brazil
por: Tavares, Patrícia Aparecida, et al.
Publicado: (2023)

Factors associated with quality of life in patients with Chagas disease: SaMi-Trop project
por: Quintino, Nayara Dornela, et al.
Publicado: (2020)

Hospitalizations due to gastrointestinal Chagas disease: National registry
por: Bierrenbach, Ana Luiza, et al.
Publicado: (2022)

Cohort profile update: the main and new findings from the SaMi-Trop Chagas cohort
por: Oliveira, Claudia Di Lorenzo, et al.
Publicado: (2021)

Overview of Chagas disease surveillance in an endemic region in Southeastern Brazil
por: Rafael, Aline Ferreira, et al.
Publicado: (2023)

Benznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of Brazil
por: Ferreira, Ariela Mota, et al.
Publicado: (2016)

Biomarkers of severity and chronification in chikungunya fever: a systematic review and meta-analysis
por: Ferreira, Andreia Silva, et al.
Publicado: (2021)

Failure to use health services by people with Chagas disease: Multilevel analysis of endemic area in Brazil
por: Damasceno, Renata Fiúza, et al.
Publicado: (2022)

Impact of the social context on the prognosis of Chagas disease patients: Multilevel analysis of a Brazilian cohort
por: Ferreira, Ariela Mota, et al.
Publicado: (2020)

Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study
por: Cardoso, Clareci Silva, et al.
Publicado: (2018)

Contextual influence on poor self-rated health in patients with Chagas disease: multilevel study
por: Ferreira, Ariela Mota, et al.
Publicado: (2022)

Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile
por: Cardoso, Clareci Silva, et al.
Publicado: (2016)

Lack of evidence of seronegative infection in an endemic area of Chagas disease
por: de Oliveira, Léa Campos, et al.
Publicado: (2019)

Left ventricular systolic dysfunction predicted by artificial intelligence using the electrocardiogram in Chagas disease patients–The SaMi-Trop cohort
por: Brito, Bruno Oliveira de Figueiredo, et al.
Publicado: (2021)

Serological screening for Chagas disease in an endemic region of Northern Minas Gerais, Brazil: the SaMi-Trop project
por: Cruz, Dardiane Santos, et al.
Publicado: (2021)

Screening for Chagas disease from the electrocardiogram using a deep neural network
por: Jidling, Carl, et al.
Publicado: (2023)

Accuracy and reliability of focused echocardiography in patients with Chagas disease from endemic areas: SaMi-Trop cohort study
por: Martins Barros, Isabella Morais, et al.
Publicado: (2021)

Challenges in the care of patients with Chagas disease in the Brazilian public health system: A qualitative study with primary health care doctors
por: Damasceno, Renata Fiúza, et al.
Publicado: (2020)

Two-year death prediction models among patients with Chagas Disease using machine learning-based methods
por: Ferreira, Ariela Mota, et al.
Publicado: (2022)

Risk Score for Predicting 2‐Year Mortality in Patients With Chagas Cardiomyopathy From Endemic Areas: SaMi‐Trop Cohort Study
por: Di Lorenzo Oliveira, Claudia, et al.
Publicado: (2020)

A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients
por: Zrein, Maan, et al.
Publicado: (2018)

Genome-wide association study for Chagas Cardiomyopathy identify a new risk locus on chromosome 18 associated with an immune-related protein and transcriptional signature
por: Sabino, Ester Cerdeira, et al.
Publicado: (2022)

Rare Pathogenic Variants in Mitochondrial and Inflammation-Associated Genes May Lead to Inflammatory Cardiomyopathy in Chagas Disease
por: Ouarhache, Maryem, et al.
Publicado: (2021)

Epidemiological indicators of Chagas disease in the metropolitan region of Salvador, Bahia, Brazil
por: Lanza, Fernanda Cardoso, et al.
Publicado: (2023)

Association between Microvolt T-Wave Alternans and Malignant Ventricular Arrhythmias in Chagas Disease
por: Almeida, Bárbara Carolina Silva, et al.
Publicado: (2018)

Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review
por: Frade, Virgínia Paula, et al.
Publicado: (2020)

Deriving a parsimonious cardiac endpoint for use in epidemiological studies of Chagas disease: results from the Retrovirus Epidemiology Donor Study-II (REDS-II) cohort
por: Buss, Lewis F., et al.
Publicado: (2021)

Prevalence and determinants of depressive symptoms in patients with Chagas cardiomyopathy and predominantly preserved cardiac function
por: Silva, Whesley Tanor, et al.
Publicado: (2020)

Mortality among blood donors seropositive and seronegative for Chagas disease (1996–2000) in São Paulo, Brazil: A death certificate linkage study
por: Capuani, Ligia, et al.
Publicado: (2017)

Correction: Mortality among blood donors seropositive and seronegative for Chagas disease (1996–2000) in São Paulo, Brazil: A death certificate linkage study
por: Capuani, Ligia, et al.
Publicado: (2020)

Quality of clinical studies present in the package inserts of coagulation factors used in the treatment of hemophilia
por: Araújo, Yasmin Gonçalves, et al.
Publicado: (2022)

Physical activity to prevent stroke mortality in Brazil (1990-2019)
por: Silva, Diego Augusto Santos, et al.
Publicado: (2022)

Temporal changes in the clinical-epidemiological profile of patients with Chagas disease at a referral center in Brazil
por: Hasslocher-Moreno, Alejandro Marcel, et al.
Publicado: (2021)

Epidemiological profile of acute Chagas disease in individuals infected by oral transmission in northern Brazil
por: Sampaio, George Harisson Felinto, et al.
Publicado: (2020)

Monitoring fluoroquinolone resistance among ESBL-positive and ESBL-negative Escherichia coli strains isolated from urinary tract infections: An alert for empirical treatment
por: Araújo, Max Roberto Batista, et al.
Publicado: (2023)

Population pharmacokinetic modeling of benznidazole in Brazilian patients with chronic Chagas disease
por: Frade, Virgínia Paula, et al.
Publicado: (2022)

Chagas Disease in the New York City Metropolitan Area
por: Zheng, Crystal, et al.
Publicado: (2020)

Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
por: Vázquez, Cristina, et al.
Publicado: (2023)

Gut Dysbiosis in Chagas Disease. A Possible Link to the Pathogenesis
por: de Souza-Basqueira, Marcela, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kj86jcju0bl8dtsocojsifm9fs